Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2407
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation ; volume:16 ; number:1 ; day:13 ; month:7 ; year:2016 ; pages:1-9 ; date:12.2016
BMC cancer ; 16, Heft 1 (13.7.2016), 1-9, 12.2016

Urheber
Han, Kelong
Beteiligte Personen und Organisationen
Claret, Laurent
Sandler, Alan
Das, Asha
Jin, Jin
Bruno, Rene
SpringerLink (Online service)

DOI
10.1186/s12885-016-2455-2
URN
urn:nbn:de:101:1-2018071223351194496139
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:23 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Han, Kelong
  • Claret, Laurent
  • Sandler, Alan
  • Das, Asha
  • Jin, Jin
  • Bruno, Rene
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a prognostic index

External validation of a prognostic index

First-line management of metastatic non-small cell lung cancer: An Indian perspective

First-line management of metastatic non-small cell lung cancer: An Indian perspective

Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

External validation of the Tyrolean hip arthroplasty registry

External validation of the Tyrolean hip arthroplasty registry

Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy

Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy

Verbundene Objekte